BVS Bioventus Inc Projected Price to Earnings

Bioventus Inc. (BVS) pricing policy is constrained by insurance limits, which deprives the company of flexibility in product pricing. Significant debt following acquisition deals and the risk of a reduction in elective procedures further intensify financial pressure. The company's forward P/E multiple demonstrates resilience to crises due to the specifics of orthopedics, and 12.00 shows the value of this parameter on the current chart.

BVS - bioventus.com Projected Price to Earnings Ratio over the range 07/04/2022 - 11/14/2026

Financial and market metric breakdowns for bioventus.com (BVS)

- stock quotes and analyst forecast:

Stock Price Bioventus Global|BVS - Analyst Median Target

- market capitalization data:

Market Valuation Bioventus Corp|BVS - Full Business Value

- issuer book value statistics:

Book Value per Share Bioventus|BVS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio bioventus.com|BVS - Total Business Assets

- company total debt and liquidity indicators:

- earnings and market ratios statistics:

BVS - Net Financial Result|Projected Future Earnings Bioventus Inc.|BVS - Price to Earnings Ratio|Forward P/E Multiple Bioventus Global|BVS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bioventus Global|BVS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Bioventus|BVS - Earnings per share for the trailing year|Quarterly EPS earnings growth bioventus.com|BVS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Bioventus Inc.

- sales and revenue data:

BVS - Company Total Sales Volume|Company Future Sales Volume Bioventus Inc|BVS - P/S Multiple|Forward P/S Multiple Bioventus Inc.

Fundamental company analysis:bioventus.com

Balance sheet restructuring and a strategic focus on orthopedics are restoring profitability for Bioventus Inc. (BVS). These operational successes directly reduce the denominator when calculating expected earnings per share. This metric correlates current market capitalization with projected income, determining the cost of one dollar of future earnings. Low values signal that the asset is undervalued. By analyzing the changes in the company's forward P/E, an investor can discern the current market consensus regarding the business's growth rates.

Competitors of Bioventus Inc. (BVS)